跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle
Approved
STANDARD
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle
Accelagen Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
677c2201d27d8cdf
Company
Accelagen Pty Ltd
Type
Standard
Approval Details
Approval Id
677c2201d27d8cdf
Product Name
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle
Artg Id
370766
Artg Name
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle
Sponsor
Accelagen Pty Ltd
Company Detail Path
/organization/accelagen-pty-ltd
Artg Date
2022-07-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01473-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01775-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
677c2201d27d8cdf
Type
Standard
Back to TGA Approvals
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle - TGA Drug Approval Details